intestine where it absorbs di/tripeptides and peptide-like compounds across the luminal membrane into enterocytes (Hu et al., 2008; Jappar et al., 2010; Yang et al., 2013) . Species differences have been observed in the PEPT1-mediated uptake of the synthetic dipeptide GlySar and the β-lactam antibiotic cefadroxil (Hu et al., 2012; Hu et al., 2014; Hu and Smith, 2016) . In the in vitro studies, yeast cells transfected with human, mouse and rat PEPT1 cDNA exhibited saturable uptake of GlySar with Km values estimated over a 5-fold range (Hu et al., 2012) .
Subsequent in situ perfusion studies in jejunum confirmed this species difference and reported 2-to 4-fold higher affinities (i.e., lower Km values) for both GlySar and cefadroxil in humanized PEPT1 mice as compared to wildtype mice (Hu et al., 2014; Hu and Smith, 2016) . Such observations, along with significant examples involving species-dependent pharmacokinetic profiles of other transporters, such as P-gp, MRP1 and BCRP (Katoh et al., 2006; Ito, 2008; Li et al., 2008; Chu et al., 2013) , demand that transporter studies be performed in different species during drug discovery, preclinical and clinical development.
Convincing data on the species-dependent functional activity of PEPT2 is generally lacking, in large part, because comparisons are made across different laboratories using different D M D # 7 3 3 2 0 6 differences in this transporter. Still, no studies have as yet systematically evaluated whether a species difference exists in the PEPT2-mediated transport of peptides/mimetics. With this in mind, the present study evaluated the uptake properties of GlySar and cefadroxil in yeast Pichia pastoris cells expressing human, mouse and rat orthologs of PEPT2. P. pastoris cells were chosen as a model system, as compared to other heterologous expression systems (e.g., HeLa, LLC-PK 1 , Xenopus oocytes), because of the lack of endogenous transport activity along with high PEPT2 functional activity (Döring et al., 1998) . Collectively, our finding demonstrated that the PEPT2-mediated uptake of GlySar and cefadroxil was species-dependent. However, Cell Culture. The recombinant P. Pastoris clones were cultured as described in the Pichia Expression Kit (https://tools.thermofisher.com/content/sfs/manuals/pich_man.pdf) (Invitrogen, Carlsbad, CA). In brief, the species-specific recombinants were cultured in a 50 mL baffled flask containing 5 mL MGY medium (1.34% YNB, 4×10
-5 % biotin and 1.0% glycerol) and grown at 30°C in a shaking incubator (250 rpm) for 18 h. Cells were pelleted at 3000 g for 5 min at room temperature, suspended in 50 mL MM medium (1.34% YNB, 4×10 -5 % biotin and
PCR was performed with species-specific primers (Table 3) to measure the gene integration copy number of PEPT2 cDNA in yeast cells (Abad et al., 2010) . The ARG4 gene was used as an internal control and the gene copy number was calculated as:
Uptake in Yeast Transformants. For uptake studies, cell cultures were harvested by centrifugation at 3000 g for 5 min at room temperature, washed once with an equal volume of 100 mM potassium phosphate buffer (PPB, 132 mL 100 mM K 2 PO 4 , 868 mL 100mM KH 2 PO 4 , pH 6.5), centrifuged and resuspended to one-fifth the volume of 100 mM PPB and stored on ice.
Uptake measurements were performed at 24°C using rapid filtration with HATF filters, as described previously (Doring et al., 1997; Doring et al., 1998) . Briefly 
10
terminated by the addition of 2 mL of ice cold 100 mM PPB, followed by filtration. The filter was washed three times with 2 mL of ice cold buffer, transferred into glass vials into which 6 mL of Cytoscint cocktail (MP Biomedicals, Solon, OH) was added, and then the radioactivity counted on a dual-channel liquid scintillation counter (Beckman LS 6000SC; Beckman Coulter, Fullerton, CA).
Data Analysis. For the concentration-dependent studies, the kinetic parameters of GlySar and cefadroxil uptake were best fit to a Michaelis-Menten equation:
where V is the observed uptake rate, V max is the maximum uptake rate, K m is the Michaelis constant and C is the substrate (GlySar or cefadroxil) concentration, after being corrected for uptake in pPIC3.5K vector control cells.
All data are reported as mean ± SE of three different experiments with each experiment being carried out in triplicate. Statistical comparisons between multiple treatment groups were determined by one-way ANOVA followed by either Tukey's or Dunnett's test (GraphPad Prism, v6.0; GraphPad Software, Inc., La Jolla, CA). A probability of p were observed between mouse and rat (Table 4) .
. Statistical analyses indicated a significant difference in Km (and Vmax) values between mice or rats and humans, but not between mice and rats. In contrast, the uptake of GlySar by vector alone was linear over this concentration range and negligible, as compared to the mammalian PEPT2 transformants (data not shown). The intrinsic clearance of GlySar (i.e., Vmax/Km) was significantly different between all three species, with rat PEPT2 (0.411±0.041
13 without effect. As expected, GlySar uptake by human, mouse and rat PEPT2 transformants was significantly reduced by the dipeptides GlyPro (≥ 90%), GlyGln (≥ 95%) and L-homocarnosine (≥ 50%), along with inhibition by the tripeptide GlyGlyHis (≥75%). With respect to peptidomimetics, the antiviral ester prodrug valacyclovir showed significant inhibition of GlySar uptake (≥ 90%), however, this uptake was not inhibited by the active moiety acyclovir.
Moreover, GlySar was inhibited by the aminocephalosporins cefadroxil, cephalexin and cephradine (≥ 90%), whereas the cephalosporins lacking an α -amino group (i.e., cephalothin and cefazolin) were without effect. Likewise, neither captopril nor the organic anion/cation SITS/TEA had an effect on GlySar uptake. Thus, it appeared that the uptake of GlySar was specific for PEPT2, being inhibited by di/tripeptides and peptide mimetics known to be
in which no significant differences in affinity were observed between mouse and rat.
Interestingly, the PEPT2 transport capacity for cefadroxil (as judged by Vmax) was much greater in humans (8.71±0.37 pmol/OD/min) than in rats (2.18±0.08 pmol/OD/min) or mice (0.22±0.01 pmol/OD/min) ( Table 5 ). The Vmax for GlySar (Table 4) , however, was the same in human and rat (i.e., 14.8±0.4 pmol/OD/min) and much greater than the value in mice (1.7±0.1 pmol/OD/min), suggesting a substrate dependence in PEPT2 capacity among the three mammalian species. The differences in Vmax do not appear to be the result of varying PEPT2
protein expression, as evaluated by immunoblot analysis (data not shown). Notwithstanding potential differences in antibody affinity between human, mouse and rat proteins, and the lack of an internal standard, the relative protein expression was ± 25% between the three mammalian species. To date, no studies have systematically evaluated whether species differences exist in the transport kinetics of PEPT2 substrates. Therefore, we used the yeast Pichia pastoris expression system to compare the uptake of GlySar and cefadroxil by human, mouse and rat PEPT2. Our results have demonstrated that: 1) the PEPT2-mediated transport of GlySar and cefadroxil was saturable, and the three mammalian species of PEPT2 had different affinities for these two substrates (Km of GlySar in human > mouse ≈ rat, and Km of cefadroxil in human >> rat ≈ mouse); 2) PEPT2-mediated transport was specific in yeast transfected with the mammalian species, studied with the uptake of GlySar being inhibited by known substrates of PEPT2; 3)
PEPT2 functional activity showed a pH dependence with an optimal uptake at 6.5 for all three species; and 4) the transport capacity of PEPT2 was substrate dependent among the three species (GlySar Vmax: human = rat >> mouse, cefadroxil Vmax: human > rat >> mouse).
In concentration-dependent studies with GlySar, we compared the dipeptide's affinities in human, mouse and rat PEPT2 transformants. In all species, μM values for K m were observed which were consistent with the high-affinity properties of PEPT2 (Brandsch et al., 2008; Rubio-Aliaga and Daniel, 2008; Smith et al., 2013) . Specifically, the GlySar Km for PEPT2
was about 4-fold higher in human (Km=151
and, as a result, species differences in PEPT2 activity were also evaluated using the clinical drug cefadroxil. Our kinetic analysis of cefadroxil uptake in yeast cells expressing human, mouse and rat PEPT2 indicated there were no significant differences in cefadroxil affinity between mouse (Km=15.6 μ Μ
) and rat (Km=11.9 μ Μ ), although an approximate 12-fold difference existed between the rodents and human (Km=150.8 μ Μ (Boll et al., 1996) , in efflux from the CSF into choroid plexus, the availability of a humanized PEPT2 mouse model might have significant utility in being able to translate PEPT2 substrate pharmacokinetics from rodent to man.
In conclusion, our studies characterized the species differences in PEPT2-mediated transport of GlySar and cefadroxil using a yeast Pichia pastoris expression system. In particular, the Km of GlySar and cefadroxil were similar in both mouse and rat, but significantly lower than that observed in human transformants. Still, the specificity and pH dependence of PEPT2 were maintained in all three mammalian species. Given that mouse and rat exhibited 4-fold and 8-to 9-fold lower Km values for GlySar and cefadroxil, respectively, it appears that these rodent models are less than optimal for translating the renal reabsorption and pharmacokinetics of peptides and peptide-like drugs in humans. Although mechanistically valuable, transporter studies in cell cultures (naïve or transfected), and other in vitro or in situ experimental systems, might not accurately reflect the outcome in vivo during human studies (Hu et al., 2014) . The establishment of humanized PEPT2 and humanized PEPT1/PEPT2 mice could provide a valuable bridge in predicting drug-drug interactions and in utilizing physiologically-based pharmacokinetic models to better predict drug performance in humans. a Gene copy number was measured by real-time PCR using human, mouse and rat PEPT2 primers, and the ARG4 gene as a control; AOX1 gene primers were used for vector alone (Table 3) .
Statistical analyses were performed using one-way ANOVA followed by Tukey's test. Parameters with common capital letters (i.e., A, B or C) were not significantly different between genotypes. Statistical analyses were performed using one-way ANOVA followed by Tukey's test. Parameters with common capital letters (i.e., A, B or C) were not significantly different between genotypes.
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